n't think there is any evidence or even any suggestion that youth would choose not to smoke if menthol products weren't available," said Bill True, senior vice president of research and development for Lorillard Tobacco Co., the makers of Newport cigarettes. "Kids don't smoke because there are menthol cigarettes. Kids smoke for a variety of reasons which are probably quite complex."
"Cigarettes do pose significant dangers to an individual's health," True added. "In dealing with regulating the product, we believe the FDA should be looking at those things that are the most significant."
On that point, anti-smoking advocates agree. Cigarettes are by their very nature a deadly product, and legislation to sharply regulate their manufacture, sale and marketing can't come a moment too soon, said Vargyas.
The National Survey on Drug Use and Health has more on menthol cigarettes.
SOURCES: Ellen Vargyas, J.D., general counsel, American Legacy Foundation, Washington, D.C.; Bill True, senior vice president, research and development, Lorillard Tobacco Co., Greensboro, N.C.; HR 1256: Family Smoking Prevention and Tobacco Control Act; U.S. National Cancer Institute, Tobacco Control Research Brand, Research Topics: Menthols and Tobacco; Harvard School of Public Health; 2009 International Journal of Clinical Practice
Page: 1 2 3 Related medicine news :1
All rights reserved
. FDA Advisers Urge Stricter Regulation of Tanning Beds2
. FDA to Broaden Disclosure on Advisers Conflicts of Interest3
. FDA Advisers Say Avastin Shouldnt Be Used for Breast Cancer4
. FDA Advisers Divided on Whether to Ban Diet Drug Meridia5
. FDA Advisers Weigh Approval of Genetically Modified Salmon6
. FDA Advisers Consider Approval of Genetically Modified Salmon7
. FDA Advisers Back Anemia Drugs for Kidney Patients8
. FDA Advisers Consider New Lupus Drug9
. FDA Advisers Endorse New Lupus Drug10
. Dalton Pharma Services and Boehringer Ingelheim (Canada) Ltd. Announce the Renewal of their Chemistry Services Agreement 11
. Reed Group and ACOEM Renew Partnership for Return-to-Work and Treatment Guidelines